FAQ

CWP232228

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2017
012320152017

Related topics

Related topics

2 relations

Broader (2)

Azabicyclo CompoundsOrganophosphates

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
CWP232228
Organophosphates
Azabicyclo Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
Cancer stem cells (CSCs), which have the potential for self-renewal, differentiation and de-differentiation, undergo epigenetic… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
Is this relevant?
2016
2016
CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment
Liver cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation, which may destroy tumor masses, but not… (More)
Is this relevant?
2015
2015
Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells.
Breast cancer stem cells (BCSC) are resistant to conventional chemotherapy and radiotherapy, which may destroy tumor masses but… (More)
Is this relevant?
2015
2015
Wnt/b-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
Breast cancer stem cells (BCSC) are resistant to conventional chemotherapy and radiotherapy, which may destroy tumor masses but… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2015
2015
Tumor and Stem Cell Biology Wnt/b-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
Breast cancer stem cells (BCSC) are resistant to conventional chemotherapy and radiotherapy, which may destroy tumor masses but… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?